Enzyme-linked immunosorbent assay (ELISA) is a test that detects antibodies in liquid biological samples. It plays a crucial role as a quality control measure in various industries and is a diagnostic tool in plant pathology and medicine. ELISA testing is extensively employed across different sectors to ensure quality assurance in product manufacturing and screen for diseases in plants and humans, facilitating early detection and appropriate interventions.
According to Data Bridge Market Research, the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market accounted for USD 2.35 billion in 2022 and is expected to reach USD 4.02 billion by 2030. The market is expected to grow with a CAGR of 6.9% in the forecast period of 2023 to 2030.
“Increasing initiatives to raise awareness”
Due to their diverse applications, the global demand for enzyme-linked immunoassay-based diagnostics is experiencing significant growth. Public awareness campaigns targeting infectious diseases like HIV have contributed to increased patient awareness and the subsequent rise in immunoassay demand. Collaborative efforts between organizations such as the International Society for Infectious Diseases have been crucial in promoting scientific knowledge exchange, public health practices, and evidence-based medicine. These factors collectively drive the growth of the enzyme-linked immunoassay market.
What restraints the growth of the enzyme-linked immunosorbent assay (ELISA) tests market?
“High cost of ELISA tests”
The high cost of ELISA tests poses a challenge to market growth. The sophisticated techniques and expensive cultural media in conducting these tests contribute to their overall cost. The need for specialized equipment and skilled personnel further adds to the expenses. As a result, the affordability and accessibility of ELISA tests have become limited, hindering their widespread adoption and potentially impacting the market growth of this diagnostic method.
Segmentation: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
The enzyme-linked immunosorbent assay (ELISA) tests market is segmented on the basis of method, application, technology, and end user.
- On the basis of the method, the enzyme-linked immunosorbent assay (ELISA) tests market is segmented into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA.
- On the basis of application, the enzyme-linked immunosorbent assay (ELISA) tests market is segmented into vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceutical industry and transplantation, infectious diseases, cancer, protein quantitation, and others.
- On the basis of technology, the enzyme-linked immunosorbent assay (ELISA) tests market is segmented into chemiluminescent, colorimetric, and fluorescent.
- On the basis of end user, the enzyme-linked immunosorbent assay (ELISA) tests market is segmented into hospitals and diagnostic centers, research laboratories.
Regional Insights: North America dominates the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
North America dominates the enzyme-linked immunosorbent assay (ELISA) tests market due to advanced healthcare infrastructure and the widespread adoption of medical devices. Moreover, government organizations and pharmaceutical companies invest in research and development activities targeting chronic ailments and diseases like diabetes. These factors contribute to the expansion of the ELISA tests market in the region, creating opportunities for further growth during the forecast period.
Asia-Pacific is expected to grow significantly due to emerging nations' increasing disposable income and healthcare expenditure. Furthermore, advanced countries are witnessing a higher adoption of medical devices, which is expected to further fuel the market growth. These factors, combined, contribute to the positive outlook for the ELISA tests market in the coming years.
To know more about the study visit, https://www.databridgemarketresearch.com/jp/reports/global-elisa-development-kits-market
Recent Developments
- In 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test
The Prominent Key Players Operating in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Include:
- Ortho Clinical Diagnostics (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Thermo Fisher Scientific (U.S.)
- Abbott (U.S.)
- ZEUS Scientific, Inc (U.S.)
- B.D. (U.S.)
- BioMérieux (France)
- Enzo Life Sciences, Inc.(U.S.)
- PerkinElmer, Inc. (U.S.)
- Merck KGaA (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- BioLegend, Inc (U.S.)
- LOEWE Biochemica GmbH (Germany)
- ELISA Technologies, Inc (U.S.).
- R&D Systems, Inc.(U.S.)
- Arbor Assays (U.S.)
- Eurofins Scientific (Luxembourg)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Agilent Technologies, Inc. (U.S.)
- Bruker (U.S.)
- Siemens (U.S.)
- General Electric (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of enzyme-linked immunosorbent assay (ELISA) tests market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
